Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker

Purpose: The objective of our study is to propose fast, cost-effective, convenient, and effective biomarkers using the perfusion parameters from dynamic contrast-enhanced ultrasound (DCE-US) for the evaluation of immune checkpoint inhibitors (ICI) early response. Methods: The retrospective cohort us...

Full description

Bibliographic Details
Main Authors: Raphael Naccache, Younes Belkouchi, Littisha Lawrance, Baya Benatsou, Joya Hadchiti, Paul-Henry Cournede, Samy Ammari, Hugues Talbot, Nathalie Lassau
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
DCE-US
perfusion
biomarker
immunotherapy
overall survival
Online Access:https://www.mdpi.com/2072-6694/14/5/1337

Internet

https://www.mdpi.com/2072-6694/14/5/1337

Similar Items